Topically administered demekastigmine bromide as a cholinesterase inhibitor.
D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*; D004912:Erythrocytes / Q000187:drug effects*; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D066298:In Vitro Techniques; D009388:Neostigmine / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use*
D002800:Cholinesterase Inhibitors; D009388:Neostigmine